Sweeny Nicole
Insider CIK 1827505 · KALV Chief Commercial Officer · MNPR Director · PRAX Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MNPR Monopar Therapeutics | A Award deriv | 2026-06-26 | 2026-06-30 | 1,284 | — | $0 | 1,284 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 40,000 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 100,000 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 68,750 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 93,750 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer | 2026-06-11 | 2026-06-11 | 59,291 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2026-05-26 | 2026-05-27 | 1,489 | $26.78 | $39.9K | 59,291 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-05-22 | 2026-05-27 | 5,000 | — | $0 | 40,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2026-05-22 | 2026-05-26 | 1,861 | $26.78 | $49.8K | 55,780 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-05-22 | 2026-05-27 | 5,000 | — | $0 | 60,780 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-05-21 | 2026-05-26 | 6,250 | — | $0 | 68,750 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-05-21 | 2026-05-26 | 6,250 | — | $0 | 57,641 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2026-04-17 | 2026-04-20 | 1,862 | $20.22 | $37.6K | 51,391 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-04-16 | 2026-04-20 | 6,250 | — | $0 | 93,750 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-04-16 | 2026-04-20 | 6,250 | — | $0 | 53,253 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2026-02-23 | 2026-02-24 | 3,975 | $15.57 | $61.9K | 47,003 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-02-22 | 2026-02-24 | 5,000 | — | $0 | 45,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-02-22 | 2026-02-24 | 5,000 | — | $0 | 50,978 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-02-21 | 2026-02-24 | 6,250 | — | $0 | 75,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-02-21 | 2026-02-24 | 6,250 | — | $0 | 45,978 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2026-01-16 | 2026-01-21 | 100,000 | — | $0 | 100,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-11-24 | 2025-12-04 | 3,813 | $13.45 | $51.3K | 39,728 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-11-22 | 2025-12-04 | 5,000 | — | $0 | 50,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-11-22 | 2025-12-04 | 5,000 | — | $0 | 43,541 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-11-21 | 2025-12-04 | 6,250 | — | $0 | 81,250 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-11-21 | 2025-12-04 | 6,250 | — | $0 | 38,541 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-08-25 | 2025-08-26 | 1,480 | $13.42 | $19.9K | 32,291 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-08-22 | 2025-08-26 | 5,000 | — | $0 | 55,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-08-22 | 2025-08-25 | 1,864 | $13.22 | $24.6K | 28,771 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-08-22 | 2025-08-26 | 5,000 | — | $0 | 33,771 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-08-21 | 2025-08-25 | 6,250 | — | $0 | 87,500 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-08-21 | 2025-08-25 | 6,250 | — | $0 | 30,635 | SEC↗ |
| PRAX Praxis Precision Medicines | F Tax w/h | 2023-02-12 | 2023-02-13 | 1,456 | $3.94 | $5.7K | 38,619 | SEC↗ |
| PRAX Praxis Precision Medicines | A Award deriv | 2023-01-12 | 2023-01-13 | 41,085 | — | $0 | 41,085 | SEC↗ |
| PRAX Praxis Precision Medicines | A Award deriv | 2023-01-12 | 2023-01-17 | 120,000 | — | $0 | 120,000 | SEC↗ |
| PRAX Praxis Precision Medicines | F Tax w/h | 2023-01-07 | 2023-01-09 | 2,079 | $2.52 | $5.2K | 40,075 | SEC↗ |
| PRAX Praxis Precision Medicines | A Award deriv | 2022-06-22 | 2022-06-24 | 65,000 | — | $0 | 65,000 | SEC↗ |
| PRAX Praxis Precision Medicines | A Award | 2022-05-13 | 2022-05-18 | 2,587 | $8.80 | $22.8K | 42,154 | SEC↗ |
| PRAX Praxis Precision Medicines | F Tax w/h | 2022-02-12 | 2022-02-15 | 1,233 | $12.85 | $15.8K | 39,567 | SEC↗ |
| PRAX Praxis Precision Medicines | A Award deriv | 2022-01-07 | 2022-01-11 | 84,000 | — | $0 | 84,000 | SEC↗ |
| PRAX Praxis Precision Medicines | A Award | 2022-01-07 | 2022-01-11 | 24,000 | — | $0 | 40,800 | SEC↗ |
| PRAX Praxis Precision Medicines | A Award deriv | 2021-02-12 | 2021-02-17 | 58,880 | — | $0 | 58,880 | SEC↗ |
| PRAX Praxis Precision Medicines | A Award | 2021-02-12 | 2021-02-17 | 16,800 | — | $0 | 16,800 | SEC↗ |